South Street Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-324,323
Closed -$10.6M 58
2020
Q1
$10.6M Sell
324,323
-8,650
-3% -$338K 3.48% 16
2019
Q4
$15.1M Buy
332,973
+13,003
+4% +$544K 3.9% 8
2019
Q3
$13M Sell
319,970
-1,370
-0.4% -$58K 3.8% 10
2019
Q2
$13.8M Sell
321,340
-610
-0.2% -$23.5K 4.11% 7
2019
Q1
$12.4M Sell
321,950
-6,590
-2% -$252K 3.75% 9
2018
Q4
$11.6M Buy
328,540
+1,440
+0.4% +$52.2K 4.1% 8
2018
Q3
$12.6K Buy
327,100
+180
+0.1% +$6.29K 1.96% 11
2018
Q2
$10.7M Buy
+326,920
New +$9.86M 3.24% 15

Other funds holding BSX

South Street Advisors's BSX Position: Q2 2020 in Review

South Street Advisors sold out of Boston Scientific (BSX) in Q2 2020, closing a stake of 324,323 shares — an estimated $10.6M sold.

South Street Advisors first reported a position in BSX in Q2 2018 and held it in 8 quarters. The position peaked at $15.1M in Q4 2019. 840 funds tracked by Wall St. Rank hold BSX as of Q2 2020.

  • South Street Advisors reported no remaining Boston Scientific position as of Q2 2020 after selling out during the quarter.
  • South Street Advisors sold 324,323 Boston Scientific shares in Q2 2020, an estimated $10.6M.
  • South Street Advisors first reported a position in Boston Scientific in Q2 2018 and held it in 8 quarters.
  • South Street Advisors's Boston Scientific position peaked at $15.1M in Q4 2019.
  • 840 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2020.

Based on South Street Advisors's 13F filing for Q2 2020, filed 4 Aug 2020.